[Arguments against implementing a population-based screening programme for colorectal cancer].

Area of Science:

• Oncology
• Public Health
• Preventive Medicine

Background:

• Faecal occult blood testing (FOBT) is an established method for colorectal cancer (CRC) screening.
• Randomized controlled trials from 1993-1996 demonstrated FOBT's efficacy in reducing CRC mortality.
• Screening led to a 1 per 10,000 person-years reduction in CRC mortality and a 50 per 10,000 person-years increase in colonoscopy rates.

Discussion:

• Population-wide CRC screening significantly increases annual healthcare expenditures for diagnosis and treatment by at least 35%.
• Physicians and informed individuals often opt out of CRC screening, suggesting a perceived low individual benefit or high burden.
• The cost-effectiveness and resource allocation for CRC screening warrant careful consideration.

Key Insights:

• FOBT screening for colorectal cancer is proven to reduce mortality.
• Screening programs incur substantial financial costs, increasing overall CRC diagnosis and treatment expenses.
• Healthcare resource allocation should prioritize patients with existing needs over broad screening of low-risk populations.

Outlook:

• Re-evaluation of current colorectal cancer screening strategies is necessary.
• Future research should focus on optimizing screening protocols for cost-effectiveness and targeted application.
• Balancing population health benefits with healthcare system capacity and financial sustainability is crucial.